Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA — EPICLIN  

NSCLC Patient Characteristics Clinical Trial

Official title: Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA

Status Active, not recruiting

Clinical Trial Summary

The study is to provide accurate, reliable information on NSCLC clinical management across MENA (Middle East North Africa) countries in order to detect unmet medical needs of this disease, it is a purely observational study; therefore patients are not assigned to a particular therapeutic strategy beforehand by a protocol. Treatment will be according to current clinical practice.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Carcinoma, Non-Small-Cell Lung
• NSCLC Patient Characteristics

• NCT number: NCT01330862
• Study type: Observational
• Source: AstraZeneca
• Status: Active, not recruiting
• Phase: N/A
• Start date: April 2011
• Completion date: March 2013